Cytosorbents (CTSO) Earnings Date & Reports

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

CTSO is expected to report earnings to fall 33.33% to -3 cents per share on August 05

Cytosorbents CTSO Stock Earnings Reports

Q2'25

Est.

$-0.04

Q1'25

Missed

by $0.01

Q4'24

Beat

by $0.02

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.01

The last earnings report on May 14 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 33.42K shares outstanding, the current market capitalization sits at 49.22M.

View a ticker or compare two or three

Compare

CTSO